Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Immucor, Inc.
WARNING LETTER
•Immucor, Inc.•January 17, 2008

Immucor, Inc. – FDA Warning Letter, Jan 17, 2008

Record Details

The FDA conducted an inspection of Immucor, Inc. in Norcross, Georgia, from January 8 to January 17, 2008, identifying violations in the manufacture of serological reagents, classified as medical devices. The inspection revealed violations of Section 501(h) of the FD&C Act and deviations from 21 CFR Part 820 (CGMP), leading to the issuance of a Form FDA 483. Significant deficiencies included the failure to establish and maintain procedures for controlling nonconforming product (21 CFR 820.90), managing changes to specifications or processes (21 CFR 820.70(b)), and handling complaints to determine Medical Device Reporting (MDR) requirements (21 CFR 820.198(a)(3)). Additionally, the firm failed to implement adequate corrective and preventive action procedures (21 CFR 820.100) and did not submit an MDR to FDA within 30 days for a device malfunction likely to cause serious injury (21 CFR 803.50(a)(2)). While Immucor submitted written responses, the FDA deemed them insufficient, particularly regarding quality assurance oversight. The firm is required to take prompt corrective action and notify the FDA within 15 working days of steps taken to correct violations and prevent recurrence. Failure to comply may result in regulatory actions, including license suspension/revocation, seizure, or injunction, and may impact federal contract awards.

Company
Immucor, Inc.
Inspection date
January 17, 2008
Product type
Drugs
Office
Office of Compliance and Enforcement
Person
  • David K. Elder (Principal)
View Company Profile

ID · a48e1c3b-0995-4b96-91db-af679d7b6ead

Violation Codes6
FD&C Act 501(h)21 CFR 820.9021 CFR 820.70(b)21 CFR 820.198(a)(3)21 CFR 820.10021 CFR 803.50(a)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Immucor, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.